Informed prostate cancer risk-adjusted testing: a new paradigm.

BJU international

Volumn 110 Suppl 4, Issue , 2012, Pages 30-34

  Stricker, Phillip D ^a   Frydenberg, Mark ^b   Kneebone, Andrew ^b   Chopra, Samarth ^b  

^a St Vincent's Prostate Cancer Centre   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BLOOD; EARLY DIAGNOSIS; HEALTH; HUMAN; INCIDENCE; MALE; MASS SCREENING; METHODOLOGY; PROSTATE TUMOR; REVIEW;

EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH;

MLCS; MLOWN;

EID: 84872901036     PISSN: None     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410x.2012.11621.x     Document Type: Review

References (0)